BOSTON ONCOLOGY ARABIA — Heparin Importer Profile
Pharmaceutical Importer · #2 buyer for Heparin · $11.0M import value · 227 shipments · SAUDI ARABIA · DGFT Verified
BOSTON ONCOLOGY ARABIA is the #2 importer of Heparin from India with $11.0M in import value and 227 verified shipments. BOSTON ONCOLOGY ARABIA holds a 3.2% market share in Heparin imports based in SAUDI ARABIA. The company sources from 1 verified supplier across 28 formulations shipped to 1 country. Overall, BOSTON ONCOLOGY ARABIA imports 5 pharmaceutical products worth $29.2M across 4 therapeutic categories.
BOSTON ONCOLOGY ARABIA — Heparin Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Heparin to BOSTON ONCOLOGY ARABIA?
Verified from 227 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| GLAND PHARMA LIMITED | $11.0M | 227 | 100.0% |
BOSTON ONCOLOGY ARABIA sources Heparin from 1 verified Indian supplier based on 227 customs records. The primary supplier is GLAND PHARMA LIMITED accounting for 100.0% of imports.
How Does BOSTON ONCOLOGY ARABIA Compare to Nearest Heparin Importers?
Buyers ranked immediately above and below #2 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | FRESENIUS KABI USA, LLC | UNITED STATES | $19.4M | 387 | $50.0K |
| 4 | EVERSANA | UNITED STATES | $13.4M | 268 | $50.0K |
| 2 | BOSTON ONCOLOGY ARABIA ★ | SAUDI ARABIA | $11.2M | 223 | $50.0K |
| 6 | FRESENIUS KABI USA LLC | UNITED STATES | $3.5M | 69 | $50.0K |
| 18 | PHARMACEUTICAL TECHNOLOGY | DOMINICAN REPUBLIC | $3.0M | 64 | $46.4K |
BOSTON ONCOLOGY ARABIA ranks #2 among 854 Heparin importers from India. Average shipment value of $50.0K compared to the market average of $80.1K. The closest competitors by value are FRESENIUS KABI USA, LLC and EVERSANA.
Where Does BOSTON ONCOLOGY ARABIA Import Heparin To?
Destination countries from 227 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| SAUDI ARABIA | $11.0M | 227 | 100.0% |
BOSTON ONCOLOGY ARABIA imports Heparin to 1 country. The primary destination is SAUDI ARABIA receiving 100.0% of shipments worth $11.0M.
What Heparin Formulations Does BOSTON ONCOLOGY ARABIA Import?
| Formulation | Value | Shipments |
|---|---|---|
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARIN | $6.4M | 130 |
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP 40MG IN 0.4ML PRE-FILLED SYRINGE | $1.2M | 24 |
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP, 40MG IN 0.4ML PRE-FILLED SYRINGE | $691.9K | 14 |
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP,80MG IN 0.8ML PRE-FILLED SYRINGE | $450.0K | 9 |
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP, 40MG IN 0.4ML PRE-FILLED SYRINGENOS | $450.0K | 9 |
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP 80MG IN 0.8ML PRE-FILLED SYRINGE | $300.0K | 6 |
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP 60MG IN 0.6ML PRE-FILLED SYRINGE | $216.6K | 5 |
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP, 20MG IN 0.2ML PREFILLED SYRINGE | $187.2K | 4 |
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP,60MG IN 0.6ML PRE-FILLED SYRINGE | $133.7K | 3 |
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINS | $100.0K | 2 |
BOSTON ONCOLOGY ARABIA imports 28 distinct Heparin formulations from India. The top formulation is LOW MOLECULAR WEIGHT HEPARIN ENOXAPARIN with 130 shipments worth $6.4M.
Who Are the Top Buyers of Heparin from India and How Much Does BOSTON ONCOLOGY ARABIA Import?
India exported $68.4M worth of Heparin through 4,586 shipments from 391 suppliers to 137 countries, serving 854 buyers globally. BOSTON ONCOLOGY ARABIA imports $11.0M of this total, accounting for 3.2% of India's Heparin exports with 227 shipments from SAUDI ARABIA. This is verified from 227 customs shipment records covering 28 distinct formulations.
What Is the Average Order Value for BOSTON ONCOLOGY ARABIA's Heparin Imports?
BOSTON ONCOLOGY ARABIA's average Heparin order value is $48.5K per consignment, based on 227 shipments totaling $11.0M. BOSTON ONCOLOGY ARABIA is based in SAUDI ARABIA and ranks #2 among all Heparin importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Heparin to BOSTON ONCOLOGY ARABIA?
BOSTON ONCOLOGY ARABIA sources Heparin from 1 verified Indian supplier: GLAND PHARMA LIMITED ($11.0M, 100.0%). This is based on 227 customs records.
How Does BOSTON ONCOLOGY ARABIA Compare to Other Heparin Importers?
BOSTON ONCOLOGY ARABIA ranks #2 among 854 Heparin importers from India with a 3.2% market share. The top 3 importers are FRESENIUS KABI USA, LLC ($19.4M), EVERSANA ($13.4M), BOSTON ONCOLOGY ARABIA ($11.2M). BOSTON ONCOLOGY ARABIA processed 227 shipments from SAUDI ARABIA.
What Other Cardiovascular Products Does BOSTON ONCOLOGY ARABIA Import?
BOSTON ONCOLOGY ARABIA also imports these cardiovascular products. Each links to the detailed product page.
About BOSTON ONCOLOGY ARABIA
BOSTON ONCOLOGY ARABIA imports 5 products worth $29.2M. Beyond Heparin, top products include Enoxaparin, Syringe, Everolimus, Dasatinib. View the complete BOSTON ONCOLOGY ARABIA profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Heparin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Heparin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: BOSTON ONCOLOGY ARABIA matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as BOSTON ONCOLOGY ARABIA's capped import value divided by total capped export value for Heparin across all Indian exporters.
- 5.Verified Records: This page is backed by 227 individual customs records matching BOSTON ONCOLOGY ARABIA importing Heparin, covering 28 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 137+ countries, 854+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Heparin Import Data for BOSTON ONCOLOGY ARABIA
Access order-level details, pricing data, supplier connections, and competitive analysis for BOSTON ONCOLOGY ARABIA's Heparin imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
BOSTON ONCOLOGY ARABIA
Full Company Profile →
5 products · $29.2M total trade · 4 categories
BOSTON ONCOLOGY ARABIA × Heparin
Verified from customs records
Company Overview
Top Products by BOSTON ONCOLOGY ARABIA
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for BOSTON ONCOLOGY ARABIA.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Heparin. For current order-level data, contact TransData Nexus.